"First, Do No Harm"-Trainees' Observation of Risk Reduction in the Treatment of Overactive Bladder

Alaina T Bennett; Nancy E Ringel; Kimia Menhaji; Oluwateniola E Brown; Evelyn F Hall; Olivia O Cardenas-Trowers; Kerac N Falk; Sarah E S Jeney; Hayley Barnes; Christina Escobar; Laura M Tellechea; Elisabeth C Sappenfield; Shailja Mehta; Olivia H Chang

doi:10.1097/SPV.0000000000000978

"First, Do No Harm"-Trainees' Observation of Risk Reduction in the Treatment of Overactive Bladder

Female Pelvic Med Reconstr Surg. 2021 Jan 1;27(1):2-4. doi: 10.1097/SPV.0000000000000978.

Authors

Affiliations

¹ From the Division of Urogynecology, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR.
² Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Medstar Washington Hospital Center and Georgetown University School of Medicine, Washington, DC.
³ Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY.
⁴ Division of Female Pelvic Medicine and Urogynecology. Department of Obstetrics and Gynecology. Northwestern University Feinberg School of Medicine, Chicago, IL.
⁵ Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, Women & Infants Hospital of Brown University, Providence, RI.
⁶ Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics, Gynecology, and Women's Health, University of Louisville School of Medicine, Louisville, KY.
⁷ Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA.
⁸ Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, University of California, Irvine School of Medicine, Irvine, CA.
⁹ Division of Female Pelvic Medicine and Reconstructive Surgery, Departments of Obstetrics and Gynecology and Urology, Loyola University Medical Center, Maywood, IL.
¹⁰ Division of Female Pelvic Medicine and Reconstructive Surgery, Departments of Obstetrics and Gynecology, New York University, New York, NY.
¹¹ Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, Einstein School of Medicine, Bronx, NY.
¹² Division of Urogynecology and Reconstructive Pelvic Surgery, Hartford Hospital, Hartford.
¹³ Division of Urogynecology & Reconstructive Pelvic Surgery, Department of Obstetrics, Gynecology & Reproductive Sciences, Yale School of Medicine, New Haven, CT.
¹⁴ Center for Urogynecology and Pelvic Reconstructive Surgery, Women's Health Institute, Cleveland Clinic, Cleveland, OH.

PMID: 33369964
DOI: 10.1097/SPV.0000000000000978

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Acetanilides / therapeutic use
Aged
Cholinergic Antagonists / adverse effects*
Dementia / chemically induced*
Dementia / epidemiology
Dementia / prevention & control
Female
Humans
Insurance Coverage
Middle Aged
Risk
Thiazoles / therapeutic use
Urinary Bladder, Overactive / drug therapy*
Urological Agents / therapeutic use

Substances

Acetanilides
Cholinergic Antagonists
Thiazoles
Urological Agents
mirabegron